An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer

肿瘤科 免疫检查点 医学 内科学 肺癌 化疗 比例危险模型 免疫系统 恶性肿瘤 免疫疗法 癌症 免疫学
作者
Le Wang,Peng Wu,Zhibo Shen,Qiuning Yu,Yulin Zhang,Fanglei Ye,Kuisheng Chen,Jie Zhao
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:117: 109827-109827 被引量:5
标识
DOI:10.1016/j.intimp.2023.109827
摘要

Therapeutic options for small cell lung cancer (SCLC), a particularly lethal malignancy, remain limited. Members of the B7-CD28 family are compelling targets for immune checkpoint blockade strategies, which involve activating, inhibiting, and fine-tuning the T cell immune response. However, their clinical features and significance have not been explored comprehensively.We enrolled 228 patients with an initial diagnosis of SCLC, including 77 cases from Cbioportal and a validation cohort of 151 cases with qPCR data. Kaplan-Meier analysis and LASSO Cox model were used to identify a signature based on the B7-CD28 family, which was applied for accurate prediction of chemotherapy benefit and prognosis for SCLC patients. In addition, we applied bioinformatics analysis to explore potential signature-related molecular mechanisms and the immune landscape.The mutation profiles of healthy tissues and SCLC tissues were distinct. A signature consisting of seven genes (CD86, ICOSLG, CD276, CD28, CTLA-4, PDCD1, and TMIGD2) was identified and applied to group patients based on risk level (high-risk and low-risk), producing two groups for which survival outcomes differed significantly (HR = 3.81, 95% CI: 2.16-6.74, P < 0.001). The immune checkpoint-based signature accurately predicted patient outcomes for the selected training and validation sets. Notably, low-risk patients were more likely to benefit from chemotherapy and showed greater immune activation. Additionally, time-dependent ROC curves and C-index analysis confirmed that the immune checkpoint-based signature has excellent predictive power for prognosis and chemotherapy benefit compared to clinically recognized parameters. Finally, multivariate analysis confirmed the identified signature as an independent risk factor for prognosis and chemotherapeutic response.We systematically obtained a comprehensive molecular profile for B7-CD28 family members in SCLC patients, from which we produced a reliable and robust prognostic immune checkpoint-based signature with the potential to improve prognostic stratification and therapy strategies for SCLC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无奈的翅膀完成签到 ,获得积分10
1秒前
JamesPei应助Gao采纳,获得10
2秒前
安可完成签到 ,获得积分10
2秒前
阳立宇关注了科研通微信公众号
3秒前
他克莫司完成签到,获得积分10
5秒前
夏傥完成签到,获得积分10
5秒前
6秒前
7秒前
Steven发布了新的文献求助30
9秒前
英姑应助昏睡的铭采纳,获得10
9秒前
不想看文献完成签到,获得积分10
10秒前
干净的寒天完成签到,获得积分10
11秒前
12秒前
12秒前
诚心谷南发布了新的文献求助10
13秒前
14秒前
烟花应助第三人称的自己采纳,获得10
15秒前
dmm完成签到 ,获得积分10
16秒前
16秒前
ycc完成签到,获得积分10
16秒前
16秒前
16秒前
嘻嘻哈哈眼药水完成签到,获得积分10
17秒前
企鹅完成签到,获得积分10
17秒前
_Y_X_L_完成签到,获得积分10
17秒前
阳立宇发布了新的文献求助10
18秒前
18秒前
科研通AI2S应助shuaishuyi采纳,获得10
19秒前
嘀嘀咕咕发布了新的文献求助10
20秒前
DT发布了新的文献求助10
20秒前
悟空应助陈强强采纳,获得10
22秒前
lina发布了新的文献求助10
22秒前
23秒前
Bebetter完成签到,获得积分10
23秒前
Peggy发布了新的文献求助10
23秒前
24秒前
Slhy完成签到 ,获得积分10
24秒前
25秒前
大喵发布了新的文献求助10
25秒前
柏林寒冬应助雷鸣惊动采纳,获得10
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989797
求助须知:如何正确求助?哪些是违规求助? 3531910
关于积分的说明 11255394
捐赠科研通 3270563
什么是DOI,文献DOI怎么找? 1805008
邀请新用户注册赠送积分活动 882157
科研通“疑难数据库(出版商)”最低求助积分说明 809190